Screener Summaries Updates Institutions Sign In More Updates › Other Events › CMND Other Events · Jun 16, 2026
On June 16, 2026, Clearmind Medicine announced the completion of dosing for Part A of its FDA-regulated Phase I/II… CMND Clearmind Medicine Inc.
On June 16, 2026, Clearmind Medicine announced the completion of dosing for Part A of its FDA-regulated Phase I/II clinical trial. The company is a pharmaceutical firm focused on developing medicines for neurological and psychiatric disorders.
More from Clearmind Medicine Inc. All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
